In MYCN-amplified NB, overexpressed MYCN protein regulates its oncogenic targets; these include MDM2 and genes of the PI3k/Akt/mTOR and STAT signaling pathways, which have anti-apoptotic and growth-promoting effects for NB cells (3, 4). Here, MDM2 is linked to neuroblastoma.